Objective: To investigate the serum versus insulin-like peptide-6 (INSL-6) levels in men with non-obstructive azoospermia (NOA) and normospermia. Study Design: Descriptive study. Place and Duration of Study: Department of Urology, Balikligol State Hospital and Harran University, Sanliurfa, Turkey, between July and October 2020. Methodology: The serum and seminal levels of INSL-6 were measured in men with NOA, and normospermia using a commercially available enzyme-linked immunosorbent assay. Age, body mass index (BMI), hormone pro le, testicular volumes and seminal and serum INSL-6 levels were compared between the study groups. Results: In total, 80 men were included in the study, 40 of whom have NOA and 40 have normospermia. No signi cant di erence was found in the mean age and BMI between the groups (p >0.05). Seminal INSL-6 levels were higher in the normospermia group, although serum and seminal INSL-6 levels were not signi cantly di erent in this group (p >0.0N5)o. signi cant correlation was observed between serum INSL-6 levels and age, BMI,testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and varicocele presence (p >0.05). No signi cant association was found between seminal INSL-6 levels and age, BMI, FSH, LH, and testosterone levels (p >0.05). However, a signi cant negative association observed between seminal INSL-6 levels and testicular volume (p <0.05). Conclusion: The seminal INSL-6 levels were approximately 5.5 times higher than theserum INSL-6 levels and survival level of INSL-6 were higher in the normospermia. This suggests that INSL-6 plays an active role in the male reproductive system. However, the mechanism and extent of this e ect remain to be elucidated.